We operate and manage our business as three operating segments: Global Generics, Global Brands and Anda Distribution.

Global Generics

Our Global Generics team drives Watson’s prominence in the global generic pharmaceutical industry. With more than 160 product families in the U.S. and a significant number of product families in International Markets (Canada, U.K., France and various other markets across Europe, South Africa, Australia, the Pacific Rim and Latin America), our portfolio is among the broadest in the industry. We are focused on bringing to market value-added products that benefit consumers and enhance our market share around the world.

Global Brands

Our Global Brands team is leveraging our scientific and manufacturing expertise to develop innovative medicines for key therapeutic categories. We are building our leadership position in Urology and Women’s Health through a portfolio of more than 36 brand products, primarily sold in the U.S. Additionally, our Global Brands team has oversight for Watson’s emergence in biopharmaceuticals – the future of medicine and a significant opportunity for our Company. We are aggressively focused on enhancing the growth of this division through international expansion and key product launches.

Anda Distribution

A unique asset within our Global Supply Chain, Anda purchases and distributes generic and select brand pharmaceutical products, vaccines, injectables and over-the-counter medicines from more than 200 suppliers (including Watson) to more than 65,000 locations, including 11,000 physician accounts, approximately 17,000 independent pharmacies, and more than 35,000 chain locations. Anda’s skilled tele-sales force and outside national accounts team drive outstanding market coverage and sales volume, making more than 18,000 calls per day. Anda is the 4th largest distributor of generic medicines in the U.S.